GeoVax Labs, Inc.
NASDAQ Capital MarketTotal Valuation
GeoVax Labs, Inc. carries a market capitalization of 88,758.00, placing it among publicly traded companies globally. Its enterprise value stands at -2.82M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 88,758.00 |
| Enterprise Value | -2.82M |
Share Statistics
GeoVax Labs, Inc. currently has 5.21M shares outstanding.
| Shares Outstanding | 5.21M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
GeoVax Labs, Inc. maintains a current ratio of 1.54, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.54 |
| Quick Ratio | 1.16 |
| Debt / Equity | 18.35 |
| Debt / EBITDA | -0.02 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -891.59 |
| Return on Assets (ROA) | -408.80 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
GeoVax Labs, Inc.'s stock has declined approximately -96.875% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.06.
| Beta (5Y) | N/A |
| 52-Week Price Change | -96.875% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.06 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -20.47M, while operating income came in at -20.53M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -20.53M |
| Pretax Income | -20.43M |
| Net Income | -20.43M |
| EBITDA | -20.47M |
| EBIT | -20.53M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
GeoVax Labs, Inc. holds 3.14M in cash and equivalents against 323,141.00 in total debt, resulting in a net debt position of -3.14M. Total book value stands at 1.76M, with working capital of 1.46M providing operational flexibility.
| Cash & Cash Equivalents | 3.14M |
| Total Debt | 323,141.00 |
| Net Debt | -3.14M |
| Equity (Book Value) | 1.76M |
| Book Value Per Share | 0.34 |
| Working Capital | 1.46M |
Cash Flow
GeoVax Labs, Inc. produced -18.37M in operating cash flow over the past twelve months.
| Operating Cash Flow | -18.37M |
| Capital Expenditures | N/A |
| Free Cash Flow | -18.37M |
| FCF Per Share | N/A |
Scores
GeoVax Labs, Inc. posts an Altman Z-Score of -63.30, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -63.30 |